目的探讨急性冠状动脉综合征(ACS)患者血浆氧化脂蛋白(a)[ox—Lp(a)]水平的变化及机制。方法分别检测96例ACS、89例非ACS患者和100例健康人血浆ox—Lp(a)水平,冠状动脉造影确认冠状动脉病变程度。结果ACS组和非ACS组ox—Lp(a)水平均高于对照组,且ACS组ox—Lp(a)水平显著高于非ACS组。ACS组ox—Lp(a)/Lp(a)比值高于非ACS组和健康对照组,后两者ee该比值无显著差别。ACS患者中ox—Lp(a)水平与冠状动脉病变程度相关(r=0.370,P=0.000),非ACS组中两者不相关(r=0.051,P=0.634)。多因素分析显示,ox—Lp(a)、TG水平及年龄解释ACS患者15.1%的病变程度。结论高ox—Lp(a)水平与ACS的发生、病变程度有关,有益于鉴别ACS。
Objective To investigate the association of increased oxidized lipoprotein(a) [ ox-Lp(a) ] levels with the severity of acute coronary syndromes (ACS) and relevant possible mechanisms. Methods Ox-Lp (a) levels were measured in 96 ACS patients, 89 non-ACS patients, and 100 healthy subjects. The extent of coronary artery disease (CAD) was determined by coronary angiography. Results Ox-Lp(a) levels significantly increased in ACS or non-ACS patients, compared with those in control. ACS patients had higher ox-Lp(a) levels than non-ACS patients. The ratio of ox-Lp(a) to Lp(a) in ACS was higher than that in either non-ACS or control, whereas the ratio was comparable between the non-ACS and control. Ox-Lp (a) levels were found to be associated with a graded increase with the severity of CAD in the ACS ( r = 0. 370, P =0. 001 ), yet not in the non-ACS ( r = 0.051, P = 0.634). Multiple linear regression analysis showed that ox-Lp( a), triglyceride, and age accounted for 15.1% of the variation in the severity of CAD in ACS patients. Conclusions Elevated ox-Lp(a) levels are associated with the presence and severity of ACS, and testing ox-Lp (a) may be useful in identifying ACS patients.